Separate names with a comma.
Down 53% after hours on news below [ATTACH] Nivalis Therapeutics (NVLS) Announces Cavosonstat Phase 2 in CF Missed Primary Endpoint Source:...
[IMG] Nivalis Therapeutics, Inc. (NVLS) is a clinical-stage pharmaceutical company. The Company discovers, develops and commercializes product...
Down 6.5% today, and another 26% after hours. Looks like most analysts are upgrading them or reiterating higher targets, not sure why it's down....
[IMG] Amicus Therapeutics, Inc. (FOLD) is a biopharmaceutical company. The Company is focused on the discovery and development of therapies to...
Upcoming Dividend Information: [ATTACH] [ATTACH]
Upcoming Dividend Information: [ATTACH][ATTACH]